The stock of Medicus Pharma Ltd (MDCX) has gone up by 6.23% for the week, with a -62.55% drop in the past month and a -14.95% drop in the past quarter. The volatility ratio for the week is 7.78%, and the volatility levels for the past 30 days are 12.99% for MDCX. The simple moving average for the past 20 days is -1.43% for MDCX’s stock, with a -20.97% simple moving average for the past 200 days.
Is It Worth Investing in Medicus Pharma Ltd (NASDAQ: MDCX) Right Now?
Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MDCX is 2.34M and currently, short sellers hold a 16.16% of that float. On June 26, 2025, MDCX’s average trading volume was 217.81K shares.
MDCX) stock’s latest price update
The stock of Medicus Pharma Ltd (NASDAQ: MDCX) has increased by 11.43 when compared to last closing price of 2.45.Despite this, the company has seen a gain of 6.23% in its stock price over the last five trading days. proactiveinvestors.com reported 2025-06-23 that Medicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical development programs in the US, Europe, and the Middle East. Smith, who most recently served as CEO of SR Asset Management until its sale in 2024, brings over 30 years of experience in financial and operational leadership.
MDCX Trading at -33.64% from the 50-Day Moving Average
After a stumble in the market that brought MDCX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.46% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDCX starting from VELOCITY FUND PARTNERS, LP, who sale 75,000 shares at the price of $7.72 back on May 20 ’25. After this action, VELOCITY FUND PARTNERS, LP now owns 3,248,741 shares of Medicus Pharma Ltd, valued at $578,940 using the latest closing price.
Stock Fundamentals for MDCX
The total capital return value is set at -6.26. Equity return is now at value -1882.04, with -435.53 for asset returns.
Based on Medicus Pharma Ltd (MDCX), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -44.15. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -16.26.
Currently, EBITDA for the company is -10.62 million with net debt to EBITDA at 0.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.53.
Conclusion
To wrap up, the performance of Medicus Pharma Ltd (MDCX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
